ScholarIQanswers from OpenAlex
Liver Diseases and Immunity
TopicLeading institutions, researchers & key papers
Liver Diseases and Immunity is a topic indexed in ScholarIQ from OpenAlex.
What is known about Liver Diseases and Immunity?
ScholarIQrecord summary
This cluster of papers focuses on the diagnosis, management, epidemiology, and genetic factors of autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. It also covers topics such as liver transplantation, immunosuppressive therapy, and the pathogenesis of these liver diseases.
How many works does Liver Diseases and Immunity have?
ScholarIQindexed works
Liver Diseases and Immunity has 369 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Liver Diseases and Immunity?
ScholarIQopenalex
The OpenAlex for Liver Diseases and Immunity is on the source record.
What are the most-cited papers on Liver Diseases and Immunity?
ScholarIQmost cited works
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Frederik Nevens, Pietro Andreoné, G. Mazzella, Simone I. Strasser, Christopher L. Bowlus, Pietro Invernizzi, Joost P.H. Drenth, Paul J. Pockros, Jarosław Reguła, Ulrich Beuers, Michael Trauner, David Jones, Annarosa Floreani, Simon Hohenester, Velimir A. Luketic, Mitchell L. Shiffman, Karel J. van Erpecum, Vı́ctor Vargas, Catherine Vincent, Gideon M. Hirschfield, Hemant Shah, Bettina E. Hansen, Keith D. Lindor, Hanns–Ulrich Marschall, Kris V. Kowdley, Roya Hooshmand-Rad, Tonya Marmon, Shawn Sheeron, Richard Pencek, Leigh MacConell, Mark Pruzanski, Д. А. Шапиро
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
Cara L. Mack, David Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, Simon C. Ling, Mouaz Alsawas, M. Hassan Murad, Albert J. Czaja
Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
Kirsten Boonstra, Rinse K. Weersma, Karel J. van Erpecum, Erik A. Rauws, B.W.M. Spanier, Alexander C. Poen, Karin M. van Nieuwkerk, Joost P.H. Drenth, Ben Witteman, Hans A.R.E. Tuynman, A.H.J. Naber, Paul J. Kingma, Henk R. van Buuren, Bart van Hoek, Frank P. Vleggaar, Nan van Geloven, Ulrich Beuers, Cyriel Y. Ponsioen, on behalf of the EpiPSCPBC Study Group
Primary sclerosing cholangitis
Gideon M. Hirschfield, Tom H. Karlsen, Keith D. Lindor, David Adams
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Tobias J. Weismüller, Palak Trivedi, Annika Bergquist, Mohamad Imam, Henrike Lenzen, Cyriel Y. Ponsioen, Kristian Holm, Daniel Gotthardt, Martti Färkkilâ, Hanns–Ulrich Marschall, Douglas Thorburn, Rinse K. Weersma, Johan Fevery, Tobias Mueller, Olivier Chazouillères, Kornelius Schulze, Konstantinos N. Lazaridis, Sven Almér, Stephen P. Pereira, Cynthia Levy, Andrew L. Mason, Sigrid Næss, Christopher L. Bowlus, Annarosa Floreani, Emina Halilbasic, Kidist Yimam, Piotr Milkiewicz, Ulrich Beuers, Dep Huynh, Albert Parés, Christine N. Manser, George Ν. Dalekos, Bertus Eksteen, Pietro Invernizzi, Christoph P. Berg, Gabi I. Kirchner, Christoph Sarrazin, Vincent Zimmer, Luca Fabris, Felix Braun, Marco Marzioni, Brian D. Juran, Karouk Said, Christian Rupp, Kalle Jokelainen, M Valle, Francesca Saffioti, Angela Cheung, Michael Trauner, Christoph Schramm, Roger W. Chapman, Tom H. Karlsen, Erik Schrumpf, Christian P. Strassburg, Michael P. Manns, Keith D. Lindor, Gideon M. Hirschfield, Bettina E. Hansen, Kirsten Muri Boberg
Where is Liver Diseases and Immunity research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Liver Diseases and Immunity is open access?
ScholarIQopen access share
60%OPEN ACCESS